Biesse (BIT:BSS) Stock Sinks As Q3 Earnings Deepen Loss Concerns

Biesse closed Friday at €4.12, capping a rough three months where the share price fell about 28% even before investors absorbed the latest Q3 2026 figures. The initial reaction has focused on another quarterly loss, with basic earnings per share at a loss of €0.08.

The longer-term picture is drawing more attention. Forecasts indicate earnings improvement and a potential path to profitability over the next few years, while the current valuation is described as a discount against estimated fair value and a low price-to-sales ratio. Short-term challenges are intersecting with a broader debate around the company’s longer-term valuation.

Interested in the longer-term story on Biesse but concerned about recent losses and valuation uncertainty? Filter for peers with stronger current profitability and cleaner balance sheets using our list of solid balance sheet and fundamentals stocks (199 results)

Q3 2026 Earnings Summary

• Revenue (Q3 2026 vs. Q3 2025): €145.457 million vs. €159.622 million (down about 8.9%)
• Net Income/Loss (Q3 2026 vs. Q3 2025): loss of €2.257 million vs. loss of €1.805 million (loss widened by about 25.0%)
• Basic EPS (Q3 2026 vs. Q2 2026): loss of €0.0849 per share vs. earnings of €0.2420 per share (moved from profit to loss)
• Trailing 12-month Net Income (Q3 2026 vs. Q3 2025): loss of €12.754 million vs. loss of €7.717 million (TTM loss increased)

Earnings are one thing, but investors who care about what a business is really worth tend to watch the cash flowing through the door rather than a single noisy quarter. If you focus on Biesse's cash flows instead of the latest loss, the stock could be a whopping 35% undervalued.

Biesse bullish story meets weaker earnings trend

Biesse is often pitched as an established industrial player backed by a global footprint and two complementary segments. The latest quarter does not yet back up a recovery angle. Revenue declined to €145.457 million while losses widened and trailing 12 month net income moved further into the red. That kind of pattern makes it harder to argue that scale, brand and diversification are already feeding through to improved profitability. Any optimistic narrative around earnings momentum now rests more on future execution rather than on what the recent income line shows.

Cyclical risks and loss profile keep bears engaged

The bearish story around Biesse focuses on cyclicality and profit pressure, and the recent figures lean in that direction. Quarterly sales fell versus last year, the period swung from earnings to a basic loss per share compared with Q2 2026, and the trailing 12 month loss deepened. Those trends fit concerns that a capex linked industrial supplier can feel demand softness quickly. Share performance, with the stock down roughly 15% over 30 days and about 28% over 90 days, shows that these profit headwinds are already front of mind for the market.

Are analysts convinced Biesse can turn operational scale into better profitability, or are targets still drifting lower? Check the consensus price target analysis for Biesse.

Hunt For Earnings Disconnects

Biesse’s weak quarter and share slide show how sentiment can turn quickly. The real opportunity could be spotting stocks that look mispriced before expectations reset.

• Company 1 - 42% below our estimate - focuses on scaling a late stage medicine pipeline so new treatments replace expiring products.
• Company 2 - 20% below our estimate - expands a teahouse network into new regions while balancing franchise returns and company store cost ratios.
• Company 3 - 23% below our estimate - shifts its mix toward higher margin prepared foods while broader cost control supports earnings from drinks and staples.

Three companies from the same screener. Open every one of the 196 undervalued companies on it →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com